ORGO Projected Dividend Yield
Organogenesis Holdings Inc ( NASDAQ : ORGO )Organogenesis Holdings Inc. is a regenerative medicine company developing solutions for advanced wound care, surgical, and sports medicine markets. It offers bioactive and acellular biomaterials, including Apligraf for venous leg ulcers and diabetic foot ulcers (DFUs), Dermagraft for DFUs, PuraPly AM as an antimicrobial barrier, and placental allografts like Affinity, Novachor, and NuShield. In sports medicine, products include NuShield as a surgical barrier and PuraForce for soft tissue repairs, along with PuraPly MZ, PuraPly AM, and PuraPly SX for managing open wounds in surgical settings. 21 YEAR PERFORMANCE RESULTS |
ORGO Dividend History Detail ORGO Dividend News ORGO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |